SCIESCOPUSQ4
Cardiovascular Endocrinology & Metabolism
LIPPINCOTT WILLIAMS & WILKINS, United States
Cardiovascular Endocrinology & Metabolism is an academic journal published by LIPPINCOTT WILLIAMS & WILKINS (United States). Identifiers: ISSN 2574-0954, eISSN 2574-0954. Indexed in SCIE, SCOPUS. Metrics: JIF 1.1, CiteScore 2.4, SJR 0.337, SNIP 0.34. Subject areas: CARDIAC & CARDIOVASCULAR SYSTEMS. tlooto lists 213 papers from this journal.
CiteScore
2.40
Scopus citation metric
SJR
0.337
SCImago rank
SNIP
0.34
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2574-0954
- eISSN
- 2574-0954
- Abbreviation
- CARDIOVASC ENDOCR ME
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2705 Cardiology and Cardiovascular Medicine2712 Endocrinology
Papers in this journal
Recent papers
- Evening salivary cortisone for evaluation of hypercortisolaemia: evaluation and implications.
2026
- Probiotic supplementation and postoperative antioxidant response in patients undergoing open‑heart surgery: a randomized controlled trial
2026 · 1 citations
- Autonomic dysfunction and insulin resistance in type 2 diabetes mellitus with hypoglycemia unawareness: an observational study
2026
- Evaluating the cardio-protective effects of Momordica balsamina in a diet-induced prediabetic rats
2026
- Adrenal adenomata displaying mild autonomous cortisol secretion: a service evaluation of cardiometabolic profile routinely screened patients.
2026
Most cited papers
- Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data
2020 · 184 citations
- Development of clinical trials to extend healthy lifespan
2018 · 69 citations
- Pathophysiology of cardiovascular disease in diabetes mellitus
2018 · 67 citations
- The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis
2021 · 51 citations
- Relative fat mass is a better predictor of dyslipidemia and metabolic syndrome than body mass index.
2019 · 49 citations